Showing results (341-350 of 511) with videos related to

Sort By:
Pageof 52
Journal of Clinical Immunology|August 15, 2013
Combined de-novo mutation and non-random X-chromosome inactivation causing Wiskott-Aldrich syndrome in a female with thrombocytopeniaBoonchai Boonyawat, Santhosh Dhanraj, Fahad Al Abbas, et al.
Stem Cells (Dayton, Ohio)|September 5, 2014
Sheep CD34+ amniotic fluid cells have hematopoietic potential and engraft after autologous in utero transplantationS W Steven Shaw, Michael P Blundell, Caterina Pipino, et al.
The Journal of Experimental Medicine|March 25, 2009
The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and functionMichela Locci, Elena Draghici, Francesco Marangoni, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Phosphorylation of WASp is a key regulator of activity and stability in vivoMichael P Blundell, Gerben Bouma, Joao Metelo, et al.
The New England Journal of Medicine|April 19, 2002
Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapySalima Hacein-Bey-Abina, Françoise Le Deist, Frédérique Carlier, et al.
Nature|September 22, 2006
Gene therapy: is IL2RG oncogenic in T-cell development?Karin Pike-Overzet, Dick de Ridder, Floor Weerkamp, et al.
The Journal of Investigative Dermatology|January 15, 2016
Lentiviral Engineered Fibroblasts Expressing Codon-Optimized COL7A1 Restore Anchoring Fibrils in RDEBChristos Georgiadis, Farhatullah Syed, Anastasia Petrova, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2012
The β-globin locus control region in combination with the EF1α short promoter allows enhanced lentiviral vector-mediated erythroid gene expression with conserved multilineage activityClaudia A Montiel-Equihua, Lin Zhang, Sean Knight, et al.
Pageof 52